Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Share
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Marine Corps Turns to AI to Help ID Pay Delays, Boost Retention
The AI-powered PULSE Check delivers real-time feedback on issues like pay delays and training gaps to help leaders improve retention.
3m read -
IT Modernization Driving AI Efficiency
Federal agencies are under pressure to modernize IT systems as AI-driven missions demand faster, more secure and resilient infrastructure.
20m read -
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
Prescription price transparency and nationwide data sharing are among the areas in which officials say technology can reduce costs.
4m read -
Army Launches Joint Innovation Outpost to Accelerate Battlefield Capabilities
At Fort Bragg, the XVIII Airborne Corps’ Joint Innovation Outpost connects soldiers, engineers and industry to accelerate battlefield capability development.
23m listen
